PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-7.32%
Both companies show declining cash positions (-7.32% vs AXSM's -3.66%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-7.32%
Cash + STI yoy ≥ 1.5x AXSM's -3.66%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-58.49%
Above 1.5x AXSM's -10.69%. Michael Burry might investigate for potential short-term asset misclassification or risk.
-6.31%
Below half of AXSM's 1.24%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-8.93%
Below half AXSM's 4.14%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.62%
Less than half of AXSM's 15.30%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-7.75%
Below half of AXSM's 1.32%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-6.35%
Below half of AXSM's 1.25%. Michael Burry sees a potential red flag for stagnation or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.18%
Less than half of AXSM's -71.60%. David Dodd sees fewer expansions in other current obligations.
5.07%
Less than half of AXSM's 17.29%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.44%
Less than half of AXSM's 3.31%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
0.54%
Less than half of AXSM's 9.16%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.80%
Below half AXSM's -7.15%. Michael Burry suspects major net losses or high dividends vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.26%
Below half AXSM's -38.63%. Michael Burry sees potential underperformance in building shareholder capital.
-6.35%
Below half AXSM's 1.25%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-8.07%
Less than half of AXSM's 0.34%. David Dodd sees less overall debt expansion vs. competitor.
7.30%
Similar yoy changes to AXSM's 9.36%. Walter Schloss sees parallel net leverage strategies.